Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 2, 2008, Pages 87-94

  Hartmann, A ^a   Krebber, R ^b   Daube, G ^c   Hartmann, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b BAYER CROPSCIENCE AG   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; PRADOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RONAXAN; UNCLASSIFIED DRUG; VERAFLOX;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INDICATION; DRUG SALIVA LEVEL; FEMALE; LACRIMAL FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 40149092179     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00932.x     Document Type: Article

References (65)

1. Abraham, J., Ewert, K. & De Jong, A. (2002) Comparative in vitro activity against selected pathogens from the US. In Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 189. American Society of Microbiology, San Diego, CA.
2. Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y., Yamamoto, T., Cha, S.H., Sekine, T., Sakthisekaran, D. & Endou, H. (2002) Human organic anion transporters mediate the transport of tetracycline. Japanese Journal of Pharmacology, 88, 69–76.
3. Van Bambeke, F. & Tulkens, P.M. (2001) Macrolides: pharmacokinetics and pharmacodynamics. International Journal of Antimicrobial Agents, 18 (Suppl. 1), S17–S23.
4. Barza, M. (1994) Challenges to antibiotic activity in tissue. Clinical Infectious Diseases, 19, 910–915.
5. Barza, M., Brown, R.B., Shanks, C., Gamble, C. & Weinstein, L. (1975) Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrobial Agents and Chemotherapy, 8, 713–720.
6. Bidgood, T.L. & Papich, M.G. (2003) Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. American Journal of Veterinary Research, 64, 1040–1046.
7. Boothe, D.M. (2006) The accumulation of pradofloxacin in phagocytes. In Abstracts of the First International Veraflox ® Symposium, pp. 18. Bayer HealthCare AG, Berlin.
8. Bregante, M.A., De Jong, A., Calvo, A., Hernandez, E., Rey, R. & Garcia, M.A. (2003) Protein binding of pradofloxacin, a novel 8‐cyanofluoroquinolone, in dog and cat plasma. Journal of Veterinary Pharmacology and Therapeutics, 26 (Suppl. 1), 87–88.
9. Butaye, P., Ducatelle, R., De Backer, P., Vermeersch, H., Remon, J.P. & Haesebrouck, F. (1997) In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys. Antimicrobial Agents and Chemotherapy, 41, 2800–2801.
10. Cavet, M.E., West, M. & Simmons, N.L. (1997) Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco‐2) cells. British Journal of Pharmacology, 121, 1567–1578.
11. Craig, W.A. & Andes, D. (1996) Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatric Infectious Disease Journal, 15, 255–259.
12. Cunha, B.A., Domenico, P. & Cunha, C.B. (2000) Pharmacodynamics of doxycycline. Clinical Microbiology and Infection, 6, 270–273.
13. Daube, G., Krebber, R. & Greife, H.A. (2006) Pharmacokinetic properties of pradofloxacin administered as an oral suspension to cats. Journal of Veterinary Pharmacology and Therapeutics, 29 (Suppl. 1), 266–267.
14. Dean, M., Hamon, Y. & Chimini, G. (2001) The human ATP‐binding cassette (ABC) transporter superfamily. Journal of Lipid Research, 42, 1007–1017.
15. Dean, R., Harley, R., Helps, C., Caney, S. & Gruffydd‐Jones, T. (2005) Use of quantitative real‐time PCR to monitor the response of Chlamydophila felis infection to doxycycline treatment. Journal of Clinical Microbiology, 43, 1858–1864.
16. Fraatz, K. (2006) Serum pharmacokinetics of pradofloxacin after oral administration to cats. Journal of Veterinary Pharmacology and Therapeutics, 29 (Suppl. 1), 266.
17. Frimodt‐Möller, N. (2002) How predictive is PK/PD for antibacterial agents? International Journal of Antimicrobial Agents, 19, 333–339.
18. Fukuda, M., Murano, H. & Sasaki, K. (1994) Dynamics of fluoroquinolone agents in tear fluid–a comparison of the dynamic in tears of human and rabbit eyes. Nippon Ganka Gakkai Zasshi, 98, 721–726.
19. Gabler, W.L. (1991) Fluxes and accumulation of tetracyclines by human blood cells. Research Communications in Chemical Pathology and Pharmacology, 72, 39–51.
20. Gerhardt, N., Schulz, B.S., Werckenthin, C. & Hartmann, K. (2006) Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Veterinary Record, 159, 591–594.
21. German, A.J., Cannon, M.J., Dye, C., Booth, M.J., Pearson, G.R., Reay, C.A. & Gruffydd‐Jones, T.J. (2005) Oesophageal strictures in cats associated with doxycycline therapy. Journal of Feline Medicine and Surgery, 7, 33–41.
22. Van Gool, F.J., Santoul, C. & Giuseppin‐Huet, A.M. (1988) Doxycycline: pharmacokinetics and suggested dosage in dogs and cats. Tijdschrift Diergeneeskunde, 13, 1189–1193.
23. Greene, C.E. (2006) Chlamydial infections. In Infectious Diseases of the Dog and Cat, 3rd edn. Ed. Greene, C.E., pp. 245–252. Saunders Elsevier Inc., St Louis.
24. Griffiths, N.M., Hirst, B.H. & Simmons, N.L. (1993) Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco‐2 cell layers. British Journal of Pharmacology, 108, 575–576.
25. Griffiths, N.M., Hirst, B.H. & Simmons, N.L. (1994) Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? Journal of Pharmacology and Experimental Therapeutics, 269, 496–502.
26. Hammerschlag, M.R. (1994) Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy, 38, 1873–1878.
27. Helps, C.R., Lait, P., Damhuis, A., Bjornehammar, U., Bolta, D., Brovida, C., Chabanne, L., Egberink, H., Ferrand, G., Fontbonne, A., Pennisi, M.G., Gruffydd‐Jones, T., Gunn‐Moore, D., Hartmann, K., Lutz, H., Malandain, E., Mostl, K., Stengel, C., Harbour, D.A. & Graat, E.A. (2005) Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Veterinary Record, 156, 669–673.
28. Himmler, T., Hallenbach, W., Marhold, A., Pirro, F., Wetzstein, H. & Bartel, S. (2002) Synthesis and in vitro activity of pradofloxacin, a novel 8‐cyanofluoroquinolone. In Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 188. American Society of Microbiology, San Diego, CA.
29. Hoeprich, P.D. & Warshauer, D.M. (1974) Entry of four tetracyclines into saliva and tears. Antimicrobial Agents and Chemotherapy, 5, 330–336.
30. De Jong, A. & Bleckmann, I. (2003) Comparative activity of pradofloxacin against clinical canine and feline strains of Germany. In Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 223. American Society of Microbiology, Chicago, IL.
31. Jusko, W.J. & Milsap, R.L. (1993) Pharmacokinetic principles of drug distribution in saliva. Annals of the New York Academy of Sciences, 694, 36–47.
32. Kelentey, B.A., Kelentey, B.J., Fekete, I. & Kozma, J. (1995) Excretion of fluoroquinolones into saliva. Fogorvosi szemle, 88, 293–297.
33. Kobayashi, Y., Ohshiro, N., Sakai, R., Ohbayashi, M., Kohyama, N. & Yamamoto, T. (2005) Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). Journal of Pharmacy and Pharmacology, 57, 573–578.
34. Koerber, B., Luhmer, E., Wetzstein, H. & Heisig, P. (2002) Bactericidal mechanisms of pradofloxacin, a novel 8‐cyanofluoroquinolone. In Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 188. American Society of Microbiology, San Diego, CA.
35. Kozjek, F., Suturkova, L.J., Antolic, G., Grabnar, I. & Mrhar, A. (1999) Kinetics of 4‐fluoroquinolones permeation into saliva. Biopharmaceutics and Drug Disposition, 20, 183–191.
36. Krebber, R. (2003) Analytical method for the determination of pradofloxacin in serum and urine by turbulent flow chromatography/tandem mass spectrometry (TFC‐MS/MS). Journal of Veterinary Pharmacology and Therapeutics, 26 (Suppl. 1), 102–103.
37. Küng, K. & Wanner, M. (1993) Einfluß zweier verschiedener Futter auf die Pharmacokinetik von oral appliziertem Baytril ® (Enrofloxacin) beim Hund. Kleintierpraxis, 38, 95–102.
38. Leggett, J.E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W., Mattie, H. & Craig, W.A. (1989) Comparative antibiotic dose‐effect relations at several dosing intervals in murine pneumonitis and thigh‐infection models. Journal of Infectious Diseases, 159, 281–292.
39. Li, Q., Naora, K., Hirano, H., Okunishi, H. & Iwamoto, K. (2002) Comparative study on salivary distribution of fluoroquinolones in rats. Biological and Pharmaceutical Bulletin, 25, 1084–1089.
40. Low, H.C., Powell, C.C., Veir, J.K., Hawley, J.R. & Lappin, M.R. (2007) Prevalence of feline herpesvirus 1, Chlamydophila felis, and Mycoplasma spp DNA in conjunctival cells collected from cats with and without conjunctivitis. Journal of the American Veterinary Medical Association, 68, 643–648.
41. Lowes, S. & Simmons, N.L. (2002) Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco‐2) cells. British Journal of Pharmacology, 135, 1263–1275.
42. Majcherczyk, J. & Szymanska‐Jachimczak, E.I. (1965) Discoloration of the teeth and bones in young animals caused by tetracycline. Zahnärztliche Praxis, 16, 61–63.
43. Mann, G.E., Smaje, L.H. & Yudilevich, D.L. (1979) Permeability of the fenestrated capillaries in the cat submandibular gland to lipid‐insoluble molecules. Journal of Physiology, 297, 335–354.
44. McGrotty, Y.L. & Knottenbelt, C.M. (2002) Oesophageal stricture in a cat due to oral administration of tetracyclines. Journal of Small Animal Practice, 43, 221–223.
45. McKellar, Q.A., Sanchez Bruni, S.F. & Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503–514.
46. Melandez, L., Twedt, D. & Wright, M. (2000) Suspected doxycycline‐induced esophagitis with esophageal stricture formation in three cats. Feline Practice, 28, 10–12.
47. Merino, G., Alvarez, A.I., Pulido, M.M., Molina, A.J., Schinkel, A.H. & Prieto, J.G. (2006) Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metabolism and Disposition, 34, 690–695.
48. Michel, G., Mosser, J. & Olle, J. (1984) Pharmacokinetics and tissue localization of doxycycline polyphosphate and doxycycline hydrochloride in the rat. European Journal of Drug Metabolism and Pharmacokinetics, 9, 149–153.
49. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G. & Alvarez, A.I. (2006) Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics, 29, 279–287.
50. Riond, J.L. & Riviere, J.E. (1989) Doxycycline binding to plasma albumin of several species. Journal of Veterinary Pharmacology and Therapeutics, 12, 253–260.
51. Riviere, J.E. & Spoo, J.W. (2001) Tetracycline antibiotics. In Veterinary Pharmacology and Therapeutics, 8th edn. Ed. Adams, H., pp. 828–840. Iowa State University Press, Ames, IA.
52. Ryan, D.M. (1993) Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. Journal of Antimicrobial Chemotherapy, 31, 1–16.
53. Sasabe, H., Kato, Y., Suzuki, T., Itose, M., Miyamoto, G. & Sugiyama, Y. (2004) Differential involvement of multidrug resistance‐associated protein 1 and P‐glycoprotein in tissue distribution and excretion of grepafloxacin in mice. Journal of Pharmacology and Experimental Therapeutics, 310, 648–655.
54. Schentag, J.J. (1989) Clinical significance of antibiotic tissue penetration. Clinical Pharmacokinetics, 16 (Suppl. 1), 25–31.
55. Schrickx, J.A. & Fink‐Gremmels, J. (2007) Danofloxacin‐mesylate is a substrate for ATP‐dependent efflux transporters. British Journal of Pharmacology, 150, 463–469.
56. Siewert, K., Rupp, J., Klinger, M., Solbach, W. & Gieffers, J. (2005) Growth cycle‐dependent pharmacodynamics of antichlamydial drugs. Antimicrobial Agents and Chemotherapy, 49, 1852–1856.
57. Sorgel, F., Jaehde, U., Naber, K. & Stephan, U. (1989) Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clinical Pharmacokinetics, 16 (Suppl. 1), 5–24.
58. Stephan, B., Pridmore, A. & Silley, P. (2003) In vitro activity of pradofloxacin and metronidazol against anaerobic bacteria from dogs and cats. In Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 223. American Society of Microbiology, Chicago, IL.
59. Sturgess, C.P., Gruffydd‐Jones, T.J., Harbour, D.A. & Jones, R.L. (2001) Controlled study of the efficacy of clavulanic acid‐potentiated amoxycillin in the treatment of Chlamydia psittaci in cats. Veterinary Record, 149, 73–76.
60. Sykes, J.E., Studdert, V.P. & Browning, G.F. (1999) Comparison of the polymerase chain reaction and culture for the detection of feline Chlamydia psittaci in untreated and doxycycline‐treated experimentally infected cats. Journal of Veterinary Internal Medicine, 13, 146–152.
61. Toutain, P.L., Del Castillo, J.R. & Bousquet‐Melou, A. (2002) The pharmacokinetic‐pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105–114.
62. Uematsu, T., Yamaoka, M., Matsuura, T., Doto, R., Hotomi, H., Yamada, A., Hasumi‐Nakayama, Y. & Kayamoto, D. (2001) P‐glycoprotein expression in human major and minor salivary glands. Archives of Oral Biology, 46, 521–527.
63. Wioland, M.A., Fleury‐Feith, J., Corlieu, P., Commo, F., Monceaux, G., Lacau‐St‐Guily, J. & Bernaudin, J.F. (2000) CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa. Journal of Histochemistry and Cytochemistry, 48, 1215–1222.
64. Yamaguchi, H., Yano, I., Hashimoto, Y. & Inui, K.I. (2000) Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco‐2. Journal of Pharmacology and Experimental Therapeutics, 295, 360–366.
65. Yang, J.J., Kim, K.J. & Lee, V.H. (2000) Role of P‐glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharmaceutical Research, 17, 533–538.